Ethris and Partners Receive Eurostars Grant for the Development of New mRNA Therapeutics for Osteoarthritis

Ethris and its partners 20Med Therapeutics, the AO Research Institute Davos and Paracelsus Medical University have received a Eurostars grant to be used to further the development of a novel approach to treating osteoarthritis. The Eurostars program is managed by the EUREKA organization and is supported by the European Union under the Horizon 2020 Framework Program.

GO TO PARTNER PRESS RELEASE
2019-10-10T12:37:47+00:00July 24th, 2019|